Please login to the form below
colorectal cancer
This page shows the latest colorectal cancer news and features for those working in and with pharma, biotech and healthcare.
MS and cholesterol drugs picked for new UK rapid uptake push
Quantitative faecal immunochemical tests for colorectal cancer - Diagnostic tests that reduce referrals for patients with suspected colorectal cancer.
Latest news
-
Home-grown colorectal cancer drug approved in China
Home-grown colorectal cancer drug approved in China. Hutchison China MediTech (Chi-Med) has been granted approval in its home market for Elunate, the first drug discovered and developed in China ... for colorectal cancer (CRC).
-
Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices
or mismatch repair deficient (dMMR) metastatic colorectal cancer. ... About 4% to 5% of metastatic colorectal cancer patients have those mutations, and make them less likely to benefit from conventional chemotherapy.
-
ACT immunotherapy cures terminal breast cancer patient
ACT immunotherapy cures terminal breast cancer patient. The new approach focuses on mutations rather than cancer type. ... The new study suggests that barrier could be overcome. Rosenberg says investigators have already tested the approach in liver and
-
Loxo, Bayer get quick FDA review for ‘precision’ cancer drug
biomarker, a departure from the usual regulatory route of seeking approval based on the organ or tissue where the cancer starts to grow. ... NTRK fusions are seen in a broad range of tumour types, including various forms of colorectal, lung, thyroid,
-
Another IO knockback as Tecentriq combo fails phase III trial
cancer (CRC) showed no benefit on overall survival compared to Bayer’s Stivarga (regorafenib), a drug typically used in that hard-to-treat population. ... In particular, we have a number of studies evaluating medicines in colorectal cancer that could
More from news
Approximately 18 fully matching, plus 231 partially matching documents found.
Latest Intelligence
-
Pharma deals continue to slide
CAP7.1 prodrug of etoposide at start phase 3 for second line treatment of biliary tract cancer. ... Phase III toll-like receptor 9 agonist for metastatic colorectal cancer. 124.
-
Winning the war against cancer
data sources and the organisation of screening programmes for colorectal cancer. ... Cancer is an important disease to see [its] impact on the health system.
-
Deal Watch September 2016
Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis. ... Janssen granted Tracon Pharmaceuticals the rights to
-
Pharma deals during February 2014
MK-3475 was awarded FDA breakthrough therapy status for advanced melanoma last year, and is being studied in 13 clinical trials across more than 30 types of cancer. ... BATON studies in colorectal cancer and metastatic triple negative breast cancer.
-
The oncology market in Canada
on the other side of the border, three tumours have comparable incidence rates, while colorectal cancer is a distant number four. ... Colorectal cancer. Colorectal cancer is where the two countries demonstrate the most substantial differences.
More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest appointments
-
BMS appoints oncology development head
On moving to the US in 2006, Dr Namouni took over responsibility for metastatic colorectal cancer treatment Erbitux (cetuximab), before serving as development lead for Opdivo (nivolumab) and Yervoy (ipilimumab).
-
Kite Pharma appoints head of regulatory affairs
colorectal cancer. ... Other recent additions include chief financial officeras chief medical officer; and several cancer experts to the company's scientific advisory board.
-
Boston Biomedical appoints commercial head
colorectal cancer.
-
Mirna hires former Pfizer director as CMO
Prior to this, he was director of clinical oncology at Bristol-Myers Squibb where he worked on the clinical development of Erbitux (cetuximab), which is approved for colorectal cancer and head ... This background will benefit Mirna, which has just
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Worldwide In-Vitro Colorectal Cancer Screening Tests Market to Soar at a 5% CAGR to 2024
Worldwide In-Vitro Colorectal Cancer Screening Tests Market to Soar at a 5% CAGR to 2024. ... Chapter 5. In-Vitro Colorectal Cancer Screening Tests Market, By Region. Chapter 6.
-
Artificial Intelligence in Healthcare
trust the same digital system to recommend their treatment pathway for a potentially lethal cancer. ... Early experience with IBM Watson for Oncology (WFO) cognitive computing system for lung and colorectal cancer treatment.
-
90TEN nominated for five Communiqué Awards
Meanwhile two of the agency’ s campaigns for Sirtex - in collaboration with Denovo Strategy - in metastatic colorectal liver cancer are shortlisted, for Excellence in Media Relations and Excellence in Integrated
-
Lynch syndrome: a patient perspective
My grandfather was probably the first in the family to be afflicted with Lynch syndrome or Hereditary Nonpolyposis Colorectal Cancer (HNPCC). ... A revolutionary discovery. For my father, the cancer came back four more times.
More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Account Manager / Account Director
-
Competative
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
- Director, Market Access / HEOR - North-West
-
Negotiable
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
Subscribe to our email news alerts
- Beta Thalassemia Testing Market: Dynamics, Segments, Size and Demand, 2016 - 2026
- Endoscope Procedure Kits Market Insights and Analysis for Period (2016-2026)
- Research Study Offers Insights on Future of Home Scales Market
- New Study Offers Detailed Insights on Hot And Cold Therapy Market
- Helicobacter Pylori Testing Market Forecast and Analysis by Future Market Insights
- Interesting Research Report on the Future of Staphylococcus Aureus Testing Market
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
